WFRF:(Kashuba Elena)
Sökning: WFRF:(Kashuba Elena) > Upregulation of PKN...
LIBRIS Formathandbok (Information om MARC21)
| Fältnamn | Indikatorer | Metadata |
|---|---|---|
| 000 | 04578naa a2200469 4500 | |
| 001 | oai:DiVA.org:oru-98917 | |
| 003 | SwePub | |
| 008 | 220510s2022 | |||||||||||000 ||eng| | |
| 009 | oai:prod.swepub.kib.ki.se:149606115 | |
| 024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-989172 URI |
| 024 | 7 | a https://doi.org/10.1177/107327482210947972 DOI |
| 024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1496061152 URI |
| 040 | a (SwePub)orud (SwePub)ki | |
| 041 | a engb eng | |
| 042 | 9 SwePub | |
| 072 | 7 | a ref2 swepub-contenttype |
| 072 | 7 | a art2 swepub-publicationtype |
| 100 | 1 | a Govorov, Igoru Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Solna, Sweden; Karolinska Institutet, Stockholm, Sweden4 aut |
| 245 | 1 0 | a Upregulation of PKN1 as a Prognosis Biomarker for Endometrial Cancer |
| 264 | c 2022-05-09 | |
| 264 | 1 | b Sage Publications,c 2022 |
| 338 | a print2 rdacarrier | |
| 500 | a Funding agencies:Cancer Research Foundation (Radiumhemmets Forskningsfonder) 151202Research Program 2.2.5.384 of NAS of Ukraine | |
| 520 | a BACKGROUND: Several markers of survival among endometrial cancer (EC) patients have been proposed, namely, the oncoprotein stathmin, RAF kinase inhibitor (RKIP), Cyclin A, GATA-binding protein 3 (GATA3), and growth and differentiation factor-15 (GDF-15). Their elevated expression correlated significantly with a high stage, serous papillary/clear cell subtypes, and aneuploidy. In a previous study, we reported the elevated expression of the serine/threonine protein kinase N1 (PKN1) in cancerous cells. In the present paper, we studied PKN1 expression in EC tissues from a large cohort of patients, to determine whether PKN1 can serve as a marker for the aggressiveness and prognosis of EC, and/or as a marker of survival among EC patients.METHODS: Tissue samples from EC patients were examined retrospectively for tumor type, tumor size, FIGO stage and grade, depth of invasion in the myometrium, and presence of lymph node metastasis. The PKN1 protein expression in EC cells was assessed by immunohistochemistry. PKN1 mRNA levels were analyzed in publicly available databases, using bioinformatic tools.RESULTS: We found that expression of PKN1 at the mRNA and proteins levels tended to increase in high-grade EC samples (P = .0001 and P = .06, respectively). In addition, patients with metastatic disease had higher PKN1 mRNA levels (P = .02). Moreover, patients with high PKN1 expression could be characterized by poorer survival.CONCLUSIONS: We have shown a trend of the higher PKN1 expression levels in EC patients with poor prognosis. Therefore, PKN1 might be considered as a candidate prognostic marker for EC. | |
| 650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
| 650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
| 653 | a PKN1 | |
| 653 | a endometrial cancer | |
| 653 | a prognostic marker | |
| 653 | a survival | |
| 653 | a tumor progression | |
| 700 | 1 | a Attarha, Sanazu Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden4 aut |
| 700 | 1 | a Kovalevska, Larysau E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of NASU, Kyiv, Ukraina4 aut |
| 700 | 1 | a Andersson, Emilu Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Solna, Sweden; Karolinska Institutet, Stockholm, Sweden4 aut |
| 700 | 1 | a Kashuba, Elenau Karolinska Institutet4 aut |
| 700 | 1 | a Mints, Miriam,d 1958-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Solna, Sweden; Karolinska Institutet, Stockholm, Sweden4 aut0 (Swepub:oru)mms |
| 710 | 2 | a Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Solna, Sweden; Karolinska Institutet, Stockholm, Swedenb Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden4 org |
| 773 | 0 | t Cancer Controld : Sage Publicationsg 29q 29x 1073-2748x 1526-2359 |
| 856 | 4 | u https://doi.org/10.1177/10732748221094797y Fulltext |
| 856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-98917 |
| 856 | 4 8 | u https://doi.org/10.1177/10732748221094797 |
| 856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:149606115 |
Hitta mer i SwePub
- Av författaren/redakt...
- Govorov, Igor
- Attarha, Sanaz
- Kovalevska, Lary ...
- Andersson, Emil
- Kashuba, Elena
- Mints, Miriam, 1 ...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Cancer och onkol ...
- Artiklar i publikationen
- Cancer Control
- Av lärosätet
- Örebro universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
